Advertisement
Journal Home
Search for

Volume 135, Issue 3, Pages 302-307 (10 July 2009)


View previous. 6 of 36 View next.

Increased muscle sympathetic nerve activity predicts mortality in heart failure patients

Antonio C.P. Barrettoa, Amilton C. Santosa, Robinson Munhoza, Maria U.P.B. Rondona, Fábio G. Francoa, Ivani C. Trombettaa, Fabiana Rovedaa, Luciana N.J. de Matosa, Ana M.W. Bragaa, Holly R. Middlekauffc, Carlos E. NegrãoabCorresponding Author Informationemail address

Received 11 December 2007; accepted 6 March 2008. published online 27 June 2008.

Abstract 

Background

Previous studies have associated neurohumoral excitation, as estimated by plasma norepinephrine levels, with increased mortality in heart failure. However, the prognostic value of neurovascular interplay in heart failure (HF) is unknown. We tested the hypothesis that the muscle sympathetic nerve activity (MSNA) and forearm blood flow would predict mortality in chronic heart failure patients.

Methods

One hundred and twenty two heart failure patients, NYHA II–IV, age 50±1 ys, LVEF 33±1%, and LVDD 7.1±0.2 mm, were followed up for one year. MSNA was directly measured from the peroneal nerve by microneurography. Forearm blood flow was obtained by venous occlusion plethysmography. The variables were analyzed by using univariate, stepwise multivariate Cox proportional hazards analysis, and Kaplan–Meier analysis.

Results

After one year, 34 pts died from cardiac death. The univariate analysis showed that MSNA, forearm blood flow, LVDD, LVEF, and heart rate were significant predictors of mortality. The multivariate analysis showed that only MSNA (P=0.001) and forearm blood flow (P=0.003) were significant independent predictors of mortality. On the basis of median levels of MSNA, survival rate was significantly lower in pts with >49 bursts/min. Similarly, survival rate was significantly lower in pts with forearm blood flow <1.87 ml/min/100 ml (P=0.002).

Conclusion

MSNA and forearm blood flow predict mortality rate in patients with heart failure. It remains unknown whether therapies that specifically target these abnormalities will improve survival in heart failure.

a Heart Institute (InCor), University of São Paulo, Medical School, Brazil

b School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil

c Department of Cardiology, University of California Los Angeles, USA

Corresponding Author InformationCorresponding author. Instituto do Coração (InCor) — Unidade de Reabilitação Cardiovascular e Fisiologia do Exercício, Av. Dr. Enéas de Carvalho Aguiar, 44 – Bloco II – 1°, Subsolo, Cerqueira César – São Paulo – SP, CEP 05403–000 — Brazil. Tel.: +55 11 3069 5699; fax: +55 11 3069 5043.

 Grants: This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo – SP (# 2005/59740-7), and in part by Fundação Zerbini, São Paulo – SP, Brazil. Carlos E Negrão (CNPq # 304304/2004-2), Maria Urbana P. B. Rondon (CNPq # 305159/2005-4), and Ivani C. Trombetta (CNPq # 306931/2006-0) were supported by Conselho Nacional de Pesquisa (CNPq).

PII: S0167-5273(08)00527-5

doi:10.1016/j.ijcard.2008.03.056


View previous. 6 of 36 View next.